528593-79-5

Upstream product

• 100-39-0 benzyl bromide 
• 172949-39-2 1,2-O-Isopropylidene-5-O-triphenylmethyl-α-L-xylofuranose 
• 114861-22-2 1,2-O-isopropylidene-α-L-xylofuranose 
• 41546-30-9 β-L-arabinose 
• 76-83-5 trityl chloride 

Downstream Products

• 391201-57-3 [(3aS,5S,6R,6aS)-6-(benzyloxy)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl]methanol 
• 917222-29-8 Benzyl-[1-((3aS,5S,6R,6aS)-6-benzyloxy-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-5-yl)-meth-(E)-ylidene]-amine 
• 528593-81-9 (2S,3S,4S,5R)-1-Benzyl-4-benzyloxy-2-methyl-piperidine-3,5-diol 
• 145772-63-0 (3aS,5R,6R,6aS)-6-Benzyloxy-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxole-5-carbaldehyde 

Relevant academic research and scientific papers

First stereocontrolled synthesis and biological evaluation of 1,6-dideoxy-L-nojirimycin

The first synthesis of 1,6-dideoxy-L-nojirimycin in enantiomerically pure form has been achieved in nine steps from L-xylose in an overall yield of 15%. The biological activity of this compound as a glycosidase inhibitor provided useful information on str